Literature DB >> 25747851

Obesity in breast cancer--what is the risk factor?

F R James1, S Wootton2, A Jackson2, M Wiseman2, E R Copson3, R I Cutress4.   

Abstract

Environmental factors influence breast cancer incidence and progression. High body mass index (BMI) is associated with increased risk of post-menopausal breast cancer and with poorer outcome in those with a history of breast cancer. High BMI is generally interpreted as excess adiposity (overweight or obesity) and the World Cancer Research Fund judged that the associations between BMI and incidence of breast cancer were due to body fatness. Although BMI is the most common measure used to characterise body composition, it cannot distinguish lean mass from fat mass, or characterise body fat distribution, and so individuals with the same BMI can have different body composition. In particular, the relation between BMI and lean or fat mass may differ between people with or without disease. The question therefore arises as to what aspect or aspects of body composition are causally linked to the poorer outcome of breast cancer patients with high BMI. This question is not addressed in the literature. Most studies have used BMI, without discussion of its shortcomings as a marker of body composition, leading to potentially important misinterpretation. In this article we review the different measurements used to characterise body composition in the literature, and how they relate to breast cancer risk and prognosis. Further research is required to better characterise the relation of body composition to breast cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body composition; Body fatness; Breast cancer; Fat free mass; Fat mass; Intervention; Prognosis; Risk factor

Mesh:

Year:  2015        PMID: 25747851     DOI: 10.1016/j.ejca.2015.01.057

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  36 in total

1.  Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2.

Authors:  Yunxiu Huang; Qianni Jin; Min Su; Feihu Ji; Nian Wang; Changli Zhong; Yulin Jiang; Yifeng Liu; Zhiqian Zhang; Junhong Yang; Lan Wei; Tingmei Chen; Bing Li
Journal:  Cell Oncol (Dordr)       Date:  2017-08-02       Impact factor: 6.730

2.  The Association Between Body Size and Breast Cancer in Han Women in Northern and Eastern China.

Authors:  Xin Wang; Liang Li; Jidong Gao; Jiaqi Liu; Mingming Guo; Liyuan Liu; Wenyan Wang; Jie Wang; Zeyu Xing; Zhigang Yu; Xiang Wang
Journal:  Oncologist       Date:  2016-08-05

3.  Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer.

Authors:  Xiuning Le; Rajee Antony; Pedram Razavi; Daniel J Treacy; Flora Luo; Mahmoud Ghandi; Pau Castel; Maurizio Scaltriti; Jose Baselga; Levi A Garraway
Journal:  Cancer Discov       Date:  2016-09-07       Impact factor: 39.397

4.  Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.

Authors:  Neil M Iyengar; Rhonda Arthur; JoAnn E Manson; Rowan T Chlebowski; Candyce H Kroenke; Lindsay Peterson; Ting-Yuan D Cheng; Elizabeth C Feliciano; Dorothy Lane; Juhua Luo; Rami Nassir; Kathy Pan; Sylvia Wassertheil-Smoller; Victor Kamensky; Thomas E Rohan; Andrew J Dannenberg
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

5.  Association between weight change and breast cancer prognosis.

Authors:  Yi-Xin Zhang; Zhuo-Zhi Liang; Yun-Qian Li; Ying Lin; Qiang Liu; Xiao-Ming Xie; Lu-Ying Tang; Ze-Fang Ren
Journal:  Breast Cancer Res Treat       Date:  2022-04-18       Impact factor: 4.872

6.  Escape from breast tumor dormancy: The convergence of obesity and menopause.

Authors:  Roopali Roy; Jiang Yang; Takaya Shimura; Lauren Merritt; Justine Alluin; Emily Man; Cassandra Daisy; Rama Aldakhlallah; Deborah Dillon; Susan Pories; Lewis A Chodosh; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

7.  Relationship of body mass index with BRAF (V600E) mutation in papillary thyroid cancer.

Authors:  Rong-Liang Shi; Ning Qu; Tian Liao; Wen-Jun Wei; Zhong-Wu Lu; Ben Ma; Yu-Long Wang; Qing-Hai Ji
Journal:  Tumour Biol       Date:  2016-01-05

8.  Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat.

Authors:  J-P Obeid; R Stoyanova; D Kwon; M Patel; K Padgett; J Slingerland; C Takita; N Alperin; M Yepes; Y H Zeidan
Journal:  Clin Transl Oncol       Date:  2016-06-30       Impact factor: 3.405

9.  Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort.

Authors:  Massimiliano D'Aiuto; Andrea Chirico; Michele Antonio De Riggi; Giuseppe Frasci; Michelino De Laurentiis; Maurizio Di Bonito; Patrizia Vici; Laura Pizzuti; Domenico Sergi; Marcello Maugeri-Saccà; Maddalena Barba; Antonio Giordano
Journal:  Cancer Biol Ther       Date:  2016-03-02       Impact factor: 4.742

Review 10.  The prognostic outcome of 'type 2 diabetes mellitus and breast cancer' association pivots on hypoxia-hyperglycemia axis.

Authors:  Ilhaam Ayaz Durrani; Attya Bhatti; Peter John
Journal:  Cancer Cell Int       Date:  2021-07-05       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.